A Selenium Containing Inhibitor for the Treatment of Hepatocellular Cancer
Hepatocellular carcinoma (HCC) is the third most deadly cancer in the world. New treatment strategies are desperately needed due to limited standard therapies. Activation of the Erk, Akt, and STAT3pathways is implicated in the prognosis of HCC. The Se,Se'-1,4-phenylenebis(1,2-ethanediyl) bisiso...
Saved in:
Main Authors: | Hephzibah Rani S. Tagaram (Author), Dhimant Desai (Author), Guangfu Li (Author), Dai Liu (Author), C. Bart Rountree (Author), Kavitha Gowda (Author), Arthur Berg (Author), Shantu Amin (Author), Kevin F. Staveley-O'Carroll (Author), Eric T. Kimchi (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2016-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Immunotherapy and Delivery System: An Update
by: Ming Yang, et al.
Published: (2022) -
Sweet Selenium: Synthesis and Properties of Selenium-Containing Sugars and Derivatives
by: Francesca Mangiavacchi, et al.
Published: (2020) -
Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma
by: Yu Xia, et al.
Published: (2019) -
Hepatocellular-Targeted mRNA Delivery Using Functionalized Selenium Nanoparticles In Vitro
by: Dhireshan Singh, et al.
Published: (2021) -
Selenium-Containing Agents Acting on Cancer-A New Hope?
by: Sabrina Garbo, et al.
Published: (2022)